Pulmonx earnings were -$48.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LUNG earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$10.1M, down 26.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LUNG reported annual earnings of -$54.0M, with -4.2% growth. The next LUNG earnings date is Nov 11, 2026.
On LUNG's earnings call on Jul 29, 2026, Pulmonx (NASDAQ: LUNG) reported Q2 2026 earnings per share (EPS) of -$0.24, up 36.84% year over year. Total LUNG earnings for the quarter were -$10.08 million. In the same quarter last year, Pulmonx's earnings per share (EPS) was -$0.38.
The next LUNG earnings date is Nov 11, 2026. Add LUNG to your watchlist to be reminded of Pulmonx's next earnings date.
Is Pulmonx profitable or losing money?
As of the last Pulmonx earnings report, Pulmonx is currently losing money. Pulmonx's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$48.12 million, a 15.5% decrease year over year.
What was LUNG's earnings growth in the past year?
As of Pulmonx's earnings date in Jul 29, 2026, Pulmonx's earnings has grown year over year. LUNG earnings in the past year totalled -$48.12 million.
What are Pulmonx's earnings expectations?
The current EPS estimate for Pulmonx's earnings report in Nov 11, 2026 is -$0.26.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.